long-term joint outcomes in patients with hemophilia: three-year results from the j-dauphin study
Published 1 year ago • 91 plays • Length 2:58Download video MP4
Download video MP3
Similar videos
-
2:45
an analysis of survival outcomes in patients with triple-class refractory myeloma
-
1:05
long-term outcomes of patients with cll treated with continuous ibrutinib
-
1:48
the promise of fitusiran for the treatment of patients with hemophilia a and b
-
1:19
the outcomes of patients with primary refractory and relapsed acute leukemia
-
0:51
unmet need in hemophilia a: breakthrough bleeds
-
3:04
fitusiran significantly reduces bleeding events in patients with hemophilia a or b, with inhibitors
-
0:45
difference between quality of life & patient-reported outcomes
-
29:31
quality of life: patient reported outcomes: purpose, types, development, and evaluation part 1
-
58:50
advancements in treatment for hemophilia
-
1:12:36
gene therapy for hemophilia and hemoglobinopathies in india: blue ribbon symposium 2018
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
2:26
improving long-term outcomes with intensive chemotherapy in aml: looking to the future
-
8:57
outcomes of sct in t-all and t-lbl
-
3:57
first-in-human gene therapy study of bay 2599023 in severe hemophilia a
-
0:48
managing patients with t-all who relapse or are refractory to first-line treatment
-
1:35
outcomes of allosct following blinatumomab in children and young adults with r/r b-all
-
2:19
maintaining remission in aml and improving long-term survival in patients who do not receive hsct
-
2:49
insights into areas of unmet need among patients with hemophilia a
-
1:22
why joint pain is common in hemophilia
-
0:39
promising therapeutic options emerging in hemophilia
-
1:33
offering personalized therapy to young and elderly patients with non-severe hemophilia